|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1030303154 |
| 003 |
OCoLC |
| 005 |
20231120010250.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
180403s2018 enk ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d N$T
|d EBLCP
|d STF
|d MERER
|d YDX
|d D6H
|d CASUM
|d OCLCQ
|d EZ9
|d OCLCQ
|d OCLCO
|d OCLCQ
|d INT
|d OCLCQ
|d U3W
|d OCLCO
|d LVT
|d OCLCA
|d OCLCQ
|d AU@
|d OCLCO
|d UKMGB
|d OCLCQ
|d OCLCA
|d S2H
|d OCLCO
|d VT2
|d OCLCQ
|d OCLCO
|d OCLCF
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBB823838
|2 bnb
|
| 016 |
7 |
|
|a 018718582
|2 Uk
|
| 019 |
|
|
|a 1030592369
|a 1030763581
|a 1043481766
|a 1059414762
|a 1229753842
|a 1235830076
|
| 020 |
|
|
|a 9780081025888
|q (electronic bk.)
|
| 020 |
|
|
|a 0081025882
|q (electronic bk.)
|
| 020 |
|
|
|z 9781785482540
|q (print)
|
| 020 |
|
|
|z 1785482548
|
| 035 |
|
|
|a (OCoLC)1030303154
|z (OCoLC)1030592369
|z (OCoLC)1030763581
|z (OCoLC)1043481766
|z (OCoLC)1059414762
|z (OCoLC)1229753842
|z (OCoLC)1235830076
|
| 050 |
|
4 |
|a QH588.S83
|
| 060 |
|
4 |
|a 2018 F-486
|
| 060 |
|
4 |
|a QU 325
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.02/774
|2 23
|
| 100 |
1 |
|
|a Arrighi, Nicole,
|e author.
|
| 245 |
1 |
0 |
|a Stem cells :
|b therapeutic innovations under control /
|c Nicole Arrighi.
|
| 264 |
|
1 |
|a London, UK :
|b ISTE Press ;
|a Kidlington, Oxford, UK :
|b Elsevier,
|c 2018.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Innovation, benefits and risk in biotechnology set
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed April 6, 2018).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Front Cover; Stem Cells: Therapeutic Innovations Under Control; Copyright; Contents; Acknowledgments; Introduction; Chapter 1. Definition and Classification of Stem Cells; 1.1. Two characteristics specific to stem cells; 1.2. Adult stem cells or specific stem cells of a tissue; 1.3. Embryonic stem cells; 1.4. Induced pluripotent stem cells; Chapter 2. Stem Cells as a Necessary Experimental Platform in Medical Research; 2.1. A tool for modeling human pathologies; 2.2. A pharmaceutical screening tool; 2.3. A predictive toxicology tool in the pharmaceutical industry.
|
| 505 |
8 |
|
|a Chapter 3. Stem Cells at the Core of Cell Therapy3.1. Blood stem cells, pioneers of cell therapy; 3.2. Skin stem cells; 3.3. Stem cells at the core of clinical research; Chapter 4. Stem Cells for Regenerative Medicine in Humans; 4.1. Biomaterials in tissue engineering; 4.2. Nanofibers associated with stem cells organized in 3D; 4.3. 3D printing from stem cells; 4.4. Today's regenerative medicine; Chapter 5. Bioethics: Regulatory Framework for Human Stem Cells; 5.1. The legal position relating to stem cell research; 5.2. The patentability of stem cell research.
|
| 505 |
8 |
|
|a 5.3. Cell- and tissue-based therapy productsGlossary; Bibliography; Index; Back Cover.
|
| 650 |
|
0 |
|a Stem cells
|x Therapeutic use.
|
| 650 |
|
0 |
|a Stem cells.
|
| 650 |
1 |
2 |
|a Stem Cells
|0 (DNLM)D013234
|
| 650 |
|
6 |
|a Cellules souches
|0 (CaQQLa)201-0058821
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
| 650 |
|
6 |
|a Cellules souches.
|0 (CaQQLa)201-0058821
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Stem cells
|2 fast
|0 (OCoLC)fst01132975
|
| 655 |
|
4 |
|a Internet Resources.
|
| 776 |
0 |
8 |
|i Print version:
|a Arrighi, Nicole.
|t Stem cells : therapeutic innovations under control.
|d London : ISTE Press ; Elsevier : Oxford, �2018
|h 194 pages
|k Innovation, entrepreneurship and management series. Innovation between risk and reward set.
|z 9780081025888
|
| 830 |
|
0 |
|a Innovation, benefits and risk in biotechnology set.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9781785482540
|z Texto completo
|
